Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes. - Kim J; Ney G; Frone MN; Haley JS; Mirshahi UL; Astiazaran-Symonds E; Shandrina M; Urban G; Rao HS; Stahl R; Golden A; Yohe ME; et al. (MedRxiv : the preprint server for health sciences, 2024)